Protara Therapeutics Inc banner

Protara Therapeutics Inc
NASDAQ:TARA

Watchlist Manager
Protara Therapeutics Inc Logo
Protara Therapeutics Inc
NASDAQ:TARA
Watchlist
Price: 4.65 USD -2.11% Market Closed
Market Cap: $251.5m

Wall St Price Targets

TARA Price Targets Summary
Protara Therapeutics Inc

Wall Street analysts forecast TARA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TARA is 26.01 USD with a low forecast of 23.23 USD and a high forecast of 31.5 USD.

Lowest Forecast
Price Target
23.23 USD
400% Upside
Average Forecast
Price Target
26.01 USD
459% Upside
Highest Forecast
Price Target
31.5 USD
577% Upside
Protara Therapeutics Inc Competitors:
Price Targets
QNST
Quinstreet Inc
58% Upside
WLFC
Willis Lease Finance Corp
30% Upside
LH6
LHC Group Inc
42% Upside
CSGP
CoStar Group Inc
60% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TARA's stock price target?
Price Target
26.01 USD

According to Wall Street analysts, the average 1-year price target for TARA is 26.01 USD with a low forecast of 23.23 USD and a high forecast of 31.5 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett